Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipoprotein(a) and Cardiovascular Disease
Pia R. Kamstrup
Clinical Chemistry (2020) Vol. 67, Iss. 1, pp. 154-166
Open Access | Times Cited: 177

Showing 26-50 of 177 citing articles:

Lipoprotein(a) and SARS‐CoV‐2 infections: Susceptibility to infections, ischemic heart disease and thromboembolic events
Silvia Di Maio, Claudia Lamina, Stefan Coassin, et al.
Journal of Internal Medicine (2021) Vol. 291, Iss. 1, pp. 101-107
Open Access | Times Cited: 33
Network Pharmacology-Based Strategy Combined with Molecular Docking and in vitro Validation Study to Explore the Underlying Mechanism of Huo Luo Xiao Ling Dan in Treating Atherosclerosis
Taoli Sun, Wenjuan Quan, Sha Peng, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 1621-1645
Open Access | Times Cited: 26
Camellia (Camellia oleifera bel.) seed oil reprograms gut microbiota and alleviates lipid accumulation in high fat-fed mice through the mTOR pathway
Jing Gao, Li Ma, Jie Yin, et al.
Food & Function (2022) Vol. 13, Iss. 9, pp. 4977-4992
Closed Access | Times Cited: 25
Daring to dream: Targeting lipoprotein(a) as a causal and risk-enhancing factor
Marlys L. Koschinsky, Erik S.G. Stroes, Florian Kronenberg
Pharmacological Research (2023) Vol. 194, pp. 106843-106843
Open Access | Times Cited: 14
Lipoprotein(a) serum concentrations in children in relation to body mass index, age and sex
Paulina Stürzebecher, Konstantin Uttinger, Mandy Vogel, et al.
Pediatric Research (2024) Vol. 96, Iss. 1, pp. 177-183
Open Access | Times Cited: 5
Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?
Georgios Tsioulos, Dimitris Kounatidis, Natalia G. Vallianou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3537-3537
Open Access | Times Cited: 5
Cardiovascular Risk Estimation and Stratification Among Individuals with Hypercholesterolemia
Giosiana Bosco, Reed Mszar, Salvatore Piro, et al.
Current Atherosclerosis Reports (2024) Vol. 26, Iss. 9, pp. 537-548
Closed Access | Times Cited: 5
Consensus on lipoprotein(a) of the Spanish Society of Arteriosclerosis. Literature review and recommendations for clinical practice
Javier Delgado‐Lista, José María Mostaza, Teresa Arrobas-Velilla, et al.
Clínica e Investigación en Arteriosclerosis (English Edition) (2024) Vol. 36, Iss. 4, pp. 243-266
Closed Access | Times Cited: 5
Lipoprotein(a) and Body Mass Compound the Risk of Calcific Aortic Valve Disease
Morten Kaltoft, Anne Langsted, Shoaib Afzal, et al.
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 6, pp. 545-558
Open Access | Times Cited: 22
Effect of Different Types and Dosages of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Lipoprotein(a) Levels: A Network Meta-analysis
Zongliang Yu, Lanqing Hu, Changxin Sun, et al.
Journal of Cardiovascular Pharmacology (2023) Vol. 81, Iss. 6, pp. 445-453
Closed Access | Times Cited: 12
Prevalence of Lp(a) in a real-world Portuguese cohort: implications for cardiovascular risk assessment
Miguel Mascarenhas, Joana Garcez, Berta Martins da Silva, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access
Persistent lipoprotein(a) exposure and its association with clinical outcomes after acute myocardial infarction: a longitudinal cohort study
Zhenwei Wang, Junnan Tang, Qian Shi, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Lipoprotein(a) molar concentrations rather than genetic variants better predict coronary artery disease risk and severity in Han Chinese population
Jie Li, Ben Ma, Qin Fang, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access
Unveiling patient profiles associated with elevated Lp(a) through an unbiased clustering analysis
Miguel Mascarenhas, Joana Garcez, Berta Martins da Silva, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
Therapeutic advances in the Lp(a) battle: what do we know and what are the most awaited novelties in the field ?
Marc Jean-Gilles, Bariş Gencer
Current Opinion in Lipidology (2025)
Closed Access
Assessment of Apolipoprotein(a) Isoform Size Using Phenotypic and Genotypic Methods
Federica Fogacci, Valentina Di Micoli, Ashot Avagimyan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13886-13886
Open Access | Times Cited: 10
Prognostic Significance of Elevated Lipoprotein (a) in Patients with Pancreatic Cancer after Radical Surgery
金月 刘
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 1471-1483
Closed Access
Statins—Their Effect on Lipoprotein(a) Levels
Marcin Mateusz Granat
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 1
Open Access
Lipoprotein(a) as a Causal Risk Factor for Cardiovascular Disease
Sean Doherty, Sebastian Hernandez, Rishi Rikhi, et al.
Current Cardiovascular Risk Reports (2025) Vol. 19, Iss. 1
Open Access
Fundamentals of lipoprotein(a) request and quantification in the clinical laboratory
Teresa Arrobas Velilla, Carla Fernández Prendes, Núria Amigó, et al.
Advances in Laboratory Medicine / Avances en Medicina de Laboratorio (2025) Vol. 6, Iss. 1, pp. 7-16
Open Access
Aspectos fundamentales en la solicitud y determinación de la lipoproteína(a) en el laboratorio clínico
Teresa Arrobas Velilla, Carla Fernández Prendes, Núria Amigó, et al.
Advances in Laboratory Medicine / Avances en Medicina de Laboratorio (2025) Vol. 6, Iss. 1, pp. 17-27
Open Access
Lipoprotein(a) levels and cardiovascular mortality risk in Chinese patients undergoing hemodialysis
Qiaojing Liang, Guojuan Zhang, Liping Jiang, et al.
International Urology and Nephrology (2025)
Closed Access
Apolipoproteins in ischemic stroke progression and recovery: Key molecular mechanisms and therapeutic potential
Tamara Etuzé, Hortense Triniac, Ze Zheng, et al.
Neurobiology of Disease (2025), pp. 106896-106896
Open Access
Combined Treatment With Lipoprotein Apheresis and Hemodialysis in Patients With Severe Cardiovascular Disease, High Lipoprotein(a) and End Stage Renal Disease
Tilmann Röseler, Daniel Kayser, Georg Schlieper, et al.
Journal of Clinical Apheresis (2025) Vol. 40, Iss. 2
Open Access
Lipoprotein(a) as a Stroke Biomarker: Pathophysiological Pathways and Therapeutic Implications
Elias Panagiotopoulos, Lina Palaiodimou, Aikaterini Theodorou, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 9, pp. 2990-2990
Open Access

Scroll to top